An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical practice, according to a study published in the journal Oncology Reports.
Molecular oncologist Fumihiro Higashino and colleagues deleted a gene involved in viral replication, called E4orf6, from a type of adenovirus. The team previously discovered that E4orf6 stabilizes a type of mRNA called ARE-mRNAs in the infected cells enabling viral replication. ARE-mRNAs are known to be stable in stressed cells and cancer cells, but rapidly degrade in normal cells.
In laboratory tests, they found that their modified adenovirus, called dl355, replicated and increased its number significantly more in cancer cells than it did in normal cells. Higashino explains “The E4orf6-lacking virus relies on the stable ARE-mRNAs in cancer cells for its replication.”
Some viruses can be used to treat cancers, as they replicate within the cells until they burst and die. The researchers infected several types of cultured cancer cells with 100 dl355 virus particles per cell and found that nearly all the cancer cells died within seven days. In contrast, most normal cells infected with the virus did not die, even after seven days. Several cancer cell lines managed to survive low doses of dl355, but all cancer cells were killed by the virus as the dose was increased. Tumour growth was also significantly suppressed when dl355 was administered to human tumour cells grown in mice.
Finally, the team compared the anticancer effects of dl355 with another anticancer adenovirus currently used in clinical practice, called dl1520. dl355 replication was higher in all cancer cell lines tested, including cervical and lung cancer cells, and was better at killing all but one type of cancer cell, compared to dl1520. Both viruses only killed very few normal cells.
The findings suggest that dl355 has potential to be an effective anticancer treatment, the team concludes. They suggest enhancing the stabilization of ARE-mRNAs in cancer cells could even further strengthen its effect, but Professor Higashino notes that further research is required. “While we think dl355 has the potential to be an effective treatment method in dealing with many types of cancers, much more research needs to be done. When we think of a timeline, at least five more years of further research may be required, possible more, on top of clinical trials,” Professor Higashino noted.
Learn more: Engineering a cancer-fighting virus
The Latest on: Engineered virus
via Google News
The Latest on: Engineered virus
- How a modified poliovirus may help fight brain canceron February 1, 2020 at 4:54 am
In their study paper — which appears in Nature Communications — the researchers explain that they have genetically modified the virus, creating a stable, safe version called a “chimera.” This modified ...
- Daily briefing: Genetically engineered gut microbes can protect honey beeson January 31, 2020 at 9:48 am
Microbes produce RNA that targets deadly bee mites and the virus they carry. Plus, the WHO has declared the coronavirus a global emergency and we hear the voice of a 3,000-year-old mummy.
- Honey Bee Microbiome Bacteria Engineered to Protect against Pathogens and Pestson January 31, 2020 at 5:07 am
[Marsha Miller/University of Texas at Austin.] Scientists at The University of Texas at Austin have harnessed specially engineered symbiotic honey bee gut bacteria to protect the insects from Varroa ...
- Engineered bacteria immunize bees against cause of colony collapseon January 30, 2020 at 7:10 pm
But now, researchers from the University of Texas at Austin have engineered bacteria that can help bees fend off two of the main causes of CCD. The two problems in question are Varroa mites and ...
- Engineered honeybee gut bacteria trick attackers into self-destructingon January 30, 2020 at 11:10 am
Deadly, fat-sucking mites and wing-wrecking viruses, take note. Specially engineered gut microbes can defend honeybees by tricking their enemies into self-destruction. The RNA’s targeted approach ...
- Bacteria engineered to protect bees from pests and pathogenson January 30, 2020 at 11:02 am
The engineered bacteria live in the guts of honey bees and act as biological factories, pumping out medicines protecting the bees against two major causes of colony collapse: Varroa mites and deformed ...
- Engineered symbionts activate honey bee immunity and limit pathogenson January 30, 2020 at 10:59 am
engineered S. alvi to produce double-stranded RNA (dsRNA)—a stimulus for insect ... alvi with specifically targeted plasmids not only suppressed infection with deformed wing virus but also effectively ...
- Sugar-derived molecules kill viruses in groundbreaking new treatmenton January 29, 2020 at 6:29 pm
The team started with molecules called cyclodextrins, which are natural derivatives of glucose. They engineered these molecules to attract viruses, then cling to their surface and tear open their ...
- Tilt Biotherapeutics, Biotheus team up on tumor-targeting viruson January 27, 2020 at 6:10 am
China’s Biotheus picked up the rights to Tilt Biotherapeutics’ lead oncolytic virus program in greater China. Tilt received an undisclosed fee upfront and stands to collect development and regulatory ...
- Mosquitoes Genetically Engineered To Resist Dengue Feveron January 24, 2020 at 5:30 pm
capable of spreading the transgene throughout wild disease-transmitting mosquito populations and preventing further [dengue virus] transmission." Gene drives are engineered constructs can quickly ...
via Bing News